11C-M503 PET

Recruiting
99 years or below
All
Phase N/A
20 participants needed
1 Location

Brief description of study

Primary Objectives 

        Determine biodistribution of the radioactive investigational drug, 11C M503 and calculate human dosimetry (at least 10 male and female participants).
        Demonstrate the feasibility of imaging the brain with the novel imaging agent 11C M503
        Determine the most appropriate data analysis methodology.
        Determine whether there is selective uptake of 11C M503 in people with MSA compared to healthy volunteers, PD and PSP participants.

Secondary Objectives

Evaluate the safety of 11C M503 biodistribution and dosimetry for 11C-M503 in humans Feasibility of imaging with 11C-M503 Comparison of PD brain uptake vs MSA, PSP and healthy controls

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 17 Jun 2025. Study ID: 23-1518

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center